Cargando…
Prevalence of Cognitive Impairment before Prostate Cancer Treatment
SIMPLE SUMMARY: The experience of a cancer diagnosis, cancer treatments, and the tumor itself may have impacts on cognitive performance. Patients with prostate cancer are a large population who may be more vulnerable to cognitive deterioration due to older age. Understanding the occurrence of cognit...
Autores principales: | Araújo, Natália, Costa, Adriana, Lopes, Catarina, Lopes-Conceição, Luisa, Ferreira, Augusto, Carneiro, Filipa, Oliveira, Jorge, Morais, Samantha, Pacheco-Figueiredo, Luís, Ruano, Luis, Tedim Cruz, Vítor, Pereira, Susana, Lunet, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909497/ https://www.ncbi.nlm.nih.gov/pubmed/35267663 http://dx.doi.org/10.3390/cancers14051355 |
Ejemplares similares
-
Anxiety and Depression in Patients with Prostate Cancer, at Cancer Diagnosis and after a One-Year Follow-Up
por: Duarte, Vítor, et al.
Publicado: (2022) -
Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC)
por: Araújo, Natália, et al.
Publicado: (2021) -
Cognitive decline in patients with prostate cancer: study protocol of a prospective cohort, NEON-PC
por: Araujo, Natalia, et al.
Publicado: (2021) -
Prevalence and Persistence of Anxiety and Depression over Five Years since Breast Cancer Diagnosis—The NEON-BC Prospective Study
por: Lopes, Catarina, et al.
Publicado: (2022) -
Trajectories of Anxiety and Depression Symptoms over Five Years since Breast Cancer Diagnosis: Results of the NEON-BC Prospective Study
por: Lopes, Catarina, et al.
Publicado: (2022)